SPRINGWORKS THERAPEUTICS, INC. Operating Cash Flow
SPRINGWORKS THERAPEUTICS, INC. reported Operating Cash Flow of -$68.76 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-05-09
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$68.76M.
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$29.50M.
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$25.38M.
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$41.79M.
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$175.60M.
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$222.79M.
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$161.56M.
- SPRINGWORKS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$127.88M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | -$68.76M 10-Q · filed 2025-05-09 | -$98.26M derived: sum of 2 quarters · filed 2025-05-09 | -$123.64M derived: sum of 3 quarters · filed 2025-05-09 | -$165.43M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-12-31 | -$29.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$54.88M derived: sum of 2 quarters · filed 2025-02-20 | -$96.67M derived: sum of 3 quarters · filed 2025-02-20 | -$175.60M 10-K · filed 2025-02-20 | |
| 2024-09-30 | -$25.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$67.17M derived: sum of 2 quarters · filed 2024-11-12 | -$146.10M 10-Q · filed 2024-11-12 | -$208.80M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-06-30 | -$41.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$120.72M 10-Q · filed 2024-08-07 | -$183.43M derived: sum of 3 quarters · filed 2025-05-09 | -$233.89M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-03-31 | -$78.93M 10-Q · filed 2025-05-09 | -$141.63M derived: sum of 2 quarters · filed 2025-05-09 | -$192.10M derived: sum of 3 quarters · filed 2025-05-09 | -$239.91M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$62.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$113.17M derived: sum of 2 quarters · filed 2025-02-20 | -$160.98M derived: sum of 3 quarters · filed 2025-02-20 | -$222.79M 10-K · filed 2025-02-20 | |
| 2023-09-30 | -$50.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$98.27M derived: sum of 2 quarters · filed 2024-11-12 | -$160.09M 10-Q · filed 2024-11-12 | -$214.29M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-06-30 | -$47.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$109.63M 10-Q · filed 2024-08-07 | -$163.83M derived: sum of 3 quarters · filed 2025-02-20 | -$183.43M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-03-31 | -$61.82M 10-Q · filed 2024-05-02 | -$116.02M derived: sum of 2 quarters · filed 2025-02-20 | -$135.62M derived: sum of 3 quarters · filed 2025-02-20 | -$174.69M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2022-12-31 | -$54.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$73.80M derived: sum of 2 quarters · filed 2025-02-20 | -$112.88M derived: sum of 3 quarters · filed 2025-02-20 | -$161.56M 10-K · filed 2025-02-20 | |
| 2022-09-30 | -$19.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$58.67M derived: sum of 2 quarters · filed 2023-11-02 | -$107.36M 10-Q · filed 2023-11-02 | -$153.68M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | -$39.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$87.76M 10-Q · filed 2023-08-02 | -$134.07M derived: sum of 3 quarters · filed 2024-02-27 | -$161.00M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | -$48.69M 10-Q · filed 2023-05-03 | -$95.00M derived: sum of 2 quarters · filed 2024-02-27 | -$121.93M derived: sum of 3 quarters · filed 2024-02-27 | -$155.46M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$46.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$73.25M derived: sum of 2 quarters · filed 2024-02-27 | -$106.77M derived: sum of 3 quarters · filed 2024-02-27 | -$127.88M 10-K · filed 2024-02-27 | |
| 2021-09-30 | -$26.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$60.46M derived: sum of 2 quarters · filed 2022-11-03 | -$81.56M 10-Q · filed 2022-11-03 | -$66.50M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$33.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$54.63M 10-Q · filed 2022-08-04 | -$39.57M derived: sum of 3 quarters · filed 2023-02-28 | -$54.27M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$21.10M 10-Q · filed 2022-05-05 | -$6.04M derived: sum of 2 quarters · filed 2023-02-28 | -$20.74M derived: sum of 3 quarters · filed 2023-02-28 | -$36.90M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $15.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $366.00K derived: sum of 2 quarters · filed 2023-02-28 | -$15.79M derived: sum of 3 quarters · filed 2023-02-28 | -$32.19M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$14.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$30.86M derived: sum of 2 quarters · filed 2021-11-04 | -$47.26M 10-Q · filed 2021-11-04 | -$63.32M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | -$16.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$32.56M 10-Q · filed 2021-08-04 | -$48.62M derived: sum of 3 quarters · filed 2022-02-24 | -$59.73M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | -$16.40M 10-Q · filed 2021-05-05 | -$32.46M derived: sum of 2 quarters · filed 2022-02-24 | -$43.57M derived: sum of 3 quarters · filed 2022-02-24 | -$56.66M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$16.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$27.18M derived: sum of 2 quarters · filed 2022-02-24 | -$40.27M derived: sum of 3 quarters · filed 2022-02-24 | -$47.44M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$11.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$24.20M derived: sum of 2 quarters · filed 2020-11-12 | -$31.38M 10-Q · filed 2020-11-12 | -$34.34M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | -$13.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$20.27M 10-Q · filed 2020-08-12 | -$23.22M derived: sum of 3 quarters · filed 2021-02-25 | ||
| 2019-03-31 | -$7.18M 10-Q · filed 2020-05-12 | -$10.13M derived: sum of 2 quarters · filed 2021-02-25 | |||
| 2018-12-31 | -$2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$14.17M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$11.21M 10-Q · filed 2019-11-12 | ||||
| 2017-12-31 | -$2.24M 10-K · filed 2020-03-12 |